Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Titel:
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Auteur:
Ferris, Robert L. Blumenschein Jr., George Fayette, Jerome Guigay, Joel Colevas, A. Dimitrios Licitra, Lisa Harrington, Kevin J. Kasper, Stefan Vokes, Everett E. Even, Caroline Worden, Francis Saba, Nabil F. Docampo, Lara Carmen Iglesias Haddad, Robert Rordorf, Tamara Kiyota, Naomi Tahara, Makoto Lynch, Mark Jayaprakash, Vijayvel Li, Li Gillison, Maura L.